Helicos BioSciences (HLCS) Lifts In Pre-Market

Posted in pre-market 
September 24th, 2009

Helicos BioSciences (HLCS) is up nearly 15% to $2.70  on news of the the publication of a landmark study in which Helicos’ True Single Molecule Sequencing (tSMS)™ technology was used to directly sequence individual molecules of RNA. The paper appeared yesterday in the on-line edition of Nature and will appear in an upcoming 2009 print issue of Nature.

The study consists of the accurate sequencing and quantitation of RNA molecules obtained directly from a biological sample without amplification, ligation or cDNA synthesis.

Douglas A. McIntyre

Comments are closed